14760-41-1 Purity
96%
If you have any other questions or need other size, please get a quote.
Reference: [1]Brown, Dean G.; Bernstein, Peter R.; Griffin, Andrew; Wesolowski, Steve; Labrecque, Denis; Tremblay, Maxime C.; Sylvester, Mark; Mauger, Russell; Edwards, Phillip D.; Throner, Scott R.; Folmer, James J.; Cacciola, Joseph; Scott, Clay; Lazor, Lois A.; Pourashraf, Mehrnaz; Santhakumar, Vijayaratnam; Potts, William M.; Sydserff, Simon; Giguère, Pascall; Lévesque, Carine; Dasser, Mohammed; Groblewski, Thierry
[Journal of Medicinal Chemistry, 2014, vol. 57, # 3, p. 733 - 758]
[2]Current Patent Assignee: QILU PHARMACEUTICAL GROUP CO LTD - CN105330698, 2016, A
[3]Current Patent Assignee: MERCK & CO INC - WO2018/68297, 2018, A1
Reference: [1]Current Patent Assignee: MERCK & CO INC - WO2018/68295, 2018, A1
Location in patent: Page/Page column 134; 135
Reference: [1]Current Patent Assignee: QILU PHARMACEUTICAL GROUP CO LTD - CN105330698, 2016, A
Location in patent: Paragraph 0778; 0779; 0780; 0781
* For details of the synthesis route, please refer to the original source to ensure accuracy.